Free UK Delivery on orders over £49

Posatex Ear Drops for dogs

Item Number: POSATEX

Posatex Ear Drops for dogs

Choose Your Options:

  • 17.5ml

    Estimated dispatch on Monday

    £ 18.29

  • 35.1ml

    Estimated dispatch on Monday

    £ 27.45

Total: £0.00

Choose options to add to basket

You are ordering a PRESCRIPTION ONLY medicine. Please do NOT continue unless you are sending us a valid prescription.



Browse other products from the Intervet product range


Posatex is for the treatment of acute otitis externa and acute exacerbations of recurrent otitis externa, associated with bacteria susceptible to orbifloxacin and fungi susceptible to posaconazole, in particular Malassezia pachydermatis.

Ear drops containing 8.5 mg/ml orbifloxacin, 0.9 mg/ml mometasone furoate (as monohydrate) and 0.9 mg/ml posaconazole.

Posatex may only be prescribed and administered by your veterinary surgeon from whom advice should be sought.

Data Sheets

Posatex® ear drops suspension for dogs Species:Dogs

Therapeutic indication:Pharmaceuticals: Antimicrobials: Topical preparations: Ear/eye/nose

Active ingredient:Mometasone Furoate, Orbifloxacin, Posaconazole

Product:Posatex® ear drops suspension for dogs

Product index:Posatex®

Withdrawal notes:Zero days

Qualitative and quantitative composition

Active substances:

Orbifloxacin 8.5 mg/mL

Mometasone furoate (as monohydrate) 0.9 mg/mL

Posaconazole 0.9 mg/mL


Paraffin liquid

For the full list of excipients, see section “Pharmaceutical particulars”.

Pharmaceutical form

Ear drops suspension.

White to off-white viscous suspension

Clinical particulars

Target Species


Indications for use

Treatment of acute otitis externa and acute exacerbations of recurrent otitis externa, associated with bacteria susceptible to orbifloxacin and fungi susceptible to posaconazole, in particular Malassezia pachydermatis.


Do not use if the eardrum is perforated.

Do not use in case of hypersensitivity to the active substances, to any of the ingredients, to corticosteroids, to other azole antifungal agents or to other fluoroquinolones.

Do not use during the whole or part of the pregnancy.

Special warnings for each target species

Bacterial and fungal otitis is often secondary in nature. The underlying cause should be identified and treated.

Special precautions for use

Heavy reliance on a single class of antibiotic may result in the induction of resistance in a bacterial population. It is prudent to reserve fluoroquinolones for the treatment of clinical conditions, which have responded poorly or are expected to respond poorly to other classes of antibiotics.

Use of the product should be based on susceptibility testing of isolated bacteria, and/or other appropriate diagnostic tests.

Quinolone class veterinary medicinal products have been associated with cartilage erosions in weight-bearing joints and other forms of arthropathy in immature animals of various species. Therefore do not use in animals less than 4 months of age.

Prolonged and intensive use of topical corticosteroids preparation is known to trigger local and systemic effects, including suppression of adrenal function, thinning of the epidermis and delayed healing. See section 4.10.

Before the veterinary medicinal product is applied, the external auditory canal must be examined thoroughly to ensure that the ear drum is not perforated in order to avoid the risk of transmission of the infection to the middle ear and to prevent damage to the cochlear and vestibular apparatus.

Operator warnings

Wash hands carefully after applying the veterinary medicinal product. Avoid skin contact. In case of accidental exposure, rinse the affected area with copious quantities of water.

Adverse Reactions

Mild erythematous lesions have been observed.

The use of auricular preparations may be associated with hearing impairment, usually temporary, and primarily in geriatric dogs.

Use during pregnancy or lactation

Do not use during the whole or part of the pregnancy.

The use of the veterinary medicinal product is not recommended during lactation.

Laboratory studies in puppies have shown evidence of arthropathy after systemic administration of orbifloxacin. Fluoroquinolones are known to cross the placenta and to be distributed into milk.

Studies to determine the effect of orbifloxacin on fertility in dogs have not been conducted.

Do not use in breeding animals.


No clinical data available.

Amounts to be administered and administration route

Auricular use.

One drop contains 267 µg orbifloxacin, 27 µg mometasone furoate and 27 µg posaconazole.

The external ear canal should be meticulously cleaned and dried before treatment. Excess hair around the treatment area should be cut.

Shake well before use.

Dogs weighing less than 2 kg, apply 2 drops to the ear once a day.

Dogs weighing 2 - 15 kg, apply 4 drops to the ear once a day.

Dogs weighing 15 kg or more, apply 8 drops to the ear once a day.

Treatment should continue for 7 consecutive days.

After application, the base of the ear may be massaged briefly and gently to allow the veterinary medicinal product to penetrate the lower part of the ear canal.


Administration of the recommended dose (4 drops per ear) 5 times daily for 21 consecutive days to dogs weighing 7.6 to 11.4 kg bodyweight caused a slight decrease in serum cortisol response after adrenocorticotropic hormone (ACTH) administration in an ACTH stimulation test. Discontinuation of treatment will result in a complete return to normal adrenal response.

Withdrawal periods

Not applicable.

Pharmacological particulars

ATC Vet Code: QS02CA91

Pharmacotherapeutic group

Otologic - Corticosteroids and anti-infectives in combination.

Pharmacodynamic properties

Orbifloxacin is a synthetic broad-spectrum bactericidal agent classified as a quinolone carboxylic acid derivative, or more specifically, a fluoroquinolone. The bactericidal action of orbifloxacin results from interference with the enzymes DNA topoisomerase II (DNA-gyrase) and DNA topoisomerase IV which are needed for the synthesis and maintenance of bacterial DNA. Such impairment disrupts replication of the bacterial cell, leading to rapid cell death. The rapidity and extent of killing are directly proportional to the drug concentration. Orbifloxacin has in vitro activity against a wide range of Gram-positive and Gram-negative organisms.

Mometasone furoate is a corticosteroid with high topical potency but little systemic effect. Like other topical corticosteroids, it has anti-inflammatory and anti-pruritic properties.

Posaconazole is a broad-spectrum triazole antifungal agent. The mechanism by which posaconazole exerts fungicidal action involves the selective inhibition of the enzyme lanosterol 14-demethylase (CYP51) involved in ergosterol biosynthesis in yeasts and filamentous fungi. In in vitro tests, posaconazole has shown fungicidal activity against most of the approximately 7,000 strains of yeast and filamentous fungi tested. Posaconazole is 40 – 100 times more potent in vitro against Malassezia pachydermatis than clotrimazole, miconazole and nystatin.

Resistance to fluoroquinolones occurs by chromosomal mutation with three mechanisms: Decrease of the bacterial wall permeability, expression of efflux pump, or mutation of enzymes responsible for the molecule’s binding site. Cross-resistance across the fluoroquinolone class of antibiotics is common. Malassezia pachydermatis resistance to azoles, including posaconazole, has not been reported.

The in vitro activity of orbifloxacin against pathogens isolated from clinical cases of canine otitis externa in an EU field trial conducted in 2000 - 2001 was:

Minimum Inhibitory Concentrations vs.Orbifloxacin-Summary

Pathogen N Min Max MIC50 MIC90
E Coli 10 0.06 0.5 0.125 0.5
Enterococci 19 0.250 16 4 8
Proteus mirabilis 9 0.5 8 1 8
Pseudomonas aeruginosa 18 1 >16 4 8
Staphylococcus intermedius 96 0.25 2 0.5 1
Stretococcus-β-haemolyticus G 19 2 4 2 4
Pharmacokinetic particulars

Systemic absorption of the active ingredients was determined in single-dose studies with [14C]-orbifloxacin, [3H]-mometasone furoate and [14C]-posaconazole contained within the Posatex formulation and placed into the ear canals of normal Beagle dogs. Most of the absorption occurred in the first few days after administration. The extent of percutaneous absorption of topical medications is determined by many factors including the integrity of the epidermal barrier. Inflammation can increase the percutaneous absorption of veterinary medicinal products.

Pharmaceutical particulars


Lauric acid

Paraffin, Liquid

Plasticised hydrocarbon gel (5% polyethylene in 95% mineral oil)

Major incompatibilities

None known.

Studies with a range of proprietary ear cleaners have shown no chemical incompatibilities.

Shelf life

Shelf life of the veterinary medicinal product as packaged for sale: 2 years

Shelf life after first opening the immediate packaging:

8.8 mL: 7 days

17.5 mL and 35.1 mL: 28 days

Special precautions for storage

This veterinary medicinal product does not require any special storage conditions.

Store in the original bottle and carton.

Immediate packaging

White HDPE bottle with a white LDPE cap, a natural or white LDPE applicator and a sheath.

Pack sizes: 8.8 mL (7.5 g), 17.5 mL (15 g) and 35.1 mL (30 g)

Not all pack sizes may be marketed.


Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.

Marketing Authorisation Holder (if different from distributor)

UK(NI): Intervet International B.V., The Netherlands

Marketing Authorisation Number

UK(GB): Vm 01708/5059

UK(NI): EU/2/08/081/001-003

Significant changes

Date of the first authorisation or date of renewal


Date of revision of the text


Any other information

For animal treatment only. Keep out of the sight and reach of children.

Legal category

Legal category:POM-V


GTIN description:Posatex 1x17.5ml:


GTIN description:Posatex 1x35.1ml:



Shipping charges mainland UK zone1

ValueWeightDelivery Charge
Over £49.00Any WeightFREE
Under £49.00No weight limit£4.50
Under £49.00Under 250g£2.99

Most orders are despatched the same day and standard delivery is 3 to 5 working days from despatch. FAST Expedited options are available.

NB: Orders placed with faster delivery must be placed before 13:00 to ensure same day dispatch (excluding weekends and bank holidays). Please also check on the product page that the items ordered show 'In Stock' otherwise your order will be delayed until the stock becomes available, which in most cases will only be 24hrs.

Estimated "Usually shipped in" information is shown against most products

Overseas orders

Postage outside of the UK is from £4.50

Prescription Items

Prescription items will be sent on receipt of a valid signed and dated prescription.

Pick up

We offer a pickup service for orders placed over the phone.

Please ring us on 01833 641112 for more information.

Refrigerated Items

Refrigerated items will be sent by carrier or Royal Mail with coolpacks unless you pay for a premium for a refrigerated delivery. We will contact you prior to despatch for your instructions.


We want you to be completely satisfied with any purchase. If not any item* can be returned to us within 14 days of receipt for exchange or refund Please give us a ring for a returns number on 01833 641112 or alternatively email [email protected] to obtain a returns number.

*Due to legal requirements medicines may not be returned except to correct an error in despatch or in response to an "official recall". If an item is believed to be faulty it should be returned for inspection and it may be necessary to forward it to the manufacturers for testing before replacements or refunds can be authorised. This does not infringe legal rights. Please contact our customer services for a "Returns Number" which must appear on the outside of the package or it will not be accepted. We advise customers to use an insured method of shipping and to retain proof of despatch. We may refuse returns on products specially obtained or manufactured to order. Items must be returned unsoiled and unused and sent adequately packed and carriage paid.

Frequently Asked Questions

There have been no questions/answers for this product so far.

Ask Question

Ask a question about Posatex Ear Drops for dogs


There have been no reviews for this product.

You Might Also Like

Hills Prescription Diet k/d Canine

Prescription Diet™ k/d™ Canine is clinically proven nutrition to support a longer and better quality of life in dogs with kidney conditions.


From £19.45 inc. VAT